The Difference Between Patient Education and Health Literacy
Understanding the difference between patient education and health literacy can assist HCPs with targeted patient engagement programs.
Opinion: How an open approach to patents could help build a sustainable future
A protectionist approach to intellectual property is designed to protect and prolong the lifecycle of existing technologies, and allow innovators to capture the profits from their creations. In a paper published with colleagues from universities in Germany and India, we examined how this also makes it harder for new and more sustainable technologies to be developed and adopted.
You are invited to the Conference Board of Canada’s webinar Placemaking & Urban Mobility: Creating Healthy & Sustainable Communities on May 30th at 2 PM EDT. This session will outline the state of research and practice related to the use of Community Design Indicator that can be used to quantify and visualize healthy built environments.
Register online for $50. Your registration includes individual access to the live session, and a recording you can share with your whole organization.
Your campaign code to quote when registering is EBIO.
Patient engagement a new frontier for drug makers
Right now, any interaction between drug companies and patients typically comes after a drug has been developed and released, when drug makers look to patients to provide “patient reported outcomes” to determine whether a drug is having its intended effects and meeting patients’ expectations.
However, the push is to engage patients earlier in the process...
Converging Markets, Technologies, and Medical Advancements Drive New Opportunities and Innovations in Digital Healthcare
New opportunities and challenges are being created as healthcare delivery evolves through the continuum of care
Seniors for Seniors: A Mentorship Program to Prevent Social Isolation and Enable Healthy Living
A 5 seminar series to engage seniors on the topic of social isolation and enable participants to design a healthy living social network. The mentorship programs seeks seniors to empower other fellow seniors through discussion, analysis and social innovation.
Singapore QuickFire Challenge - Metabolic Disease Innovation
The QuickFire Challenge will award the entrepreneur, academic, and biotech researchers who submit the best ideas, technologies, or solutions holding the potential of making a major difference to the millions of people in Asia Pacific and around the world who suffer from metabolic diseases such as diabetes and obesity. Winners will be awarded with SGD100,000 project money, access to ETPL laboratory space and one year of mentorship and coaching by Johnson & Johnson Innovation, ETPL and SMART staff.
The initiative underscores Johnson & Johnson’s strong commitment to working in partnership to nurture the healthcare ecosystem in global innovation hotspots around the world, like Singapore, with the aim of positively impacting human health through innovation. The Challenge demonstrates Johnson & Johnson Innovation’s unique vision for collaboration in an open innovation model, aiming to combine Johnson & Johnson Innovation’s global reach and expertise with Singapore’s unique capabilities in innovation to identify breakthrough solutions for the diagnosis and/or treatment of metabolic diseases.
Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.
The Evolution of Patient Engagement at FDA
Although advancements in incorporating the patient voice have been made over the past few decades, there are still patients who feel frustrated with the rate of progress.
Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
This is the question eyeforpharma answers in its latest whitepaper on GSK's radical new customer engagement model. Read the full paper here https://goo.gl/w0H9k7
Lessons for Patient Driven Innovation: Rebuild Personas According to Your Next Product Innovation
By exclusively focusing on your persona’s one main need and trying hard to fulfill that need with your product, you can build the next feature with a more focused vision.
Culture and Process Change for Patient Engagement
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions. Read More...
Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.
Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.
It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.
Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.
WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.